Correction: CLC3 regulates V-ATPase to enhance lysosomal degradation and cisplatin resistance in cervical cancer cells

Key Points

• The research aims to investigate how CLC3 affects V-ATPase activity and its implications for cisplatin resistance in cervical cancer cells.
• Conducted preliminary experiments in 24-well plates
• Conducted formal experiments in 6-well plates
• Analyzed the effects of CLC3 on lysosomal degradation and cisplatin resistance.
• Formal results reaffirmed the conclusion despite experimental differences
• CLC3 is involved in enhancing lysosomal degradation
• Cisplatin resistance is linked to the activity of V-ATPase regulated by CLC3.